Covid Vaccines Targeting Omicron Should Be Standard, Panel Says
As advisers to the Food and Drug Administration endorsed ending [...]
Why Kids’ Medication Shortages Aren’t Going Away
There are weaknesses baked into the supply chain.
FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early [...]
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says
Mifepristone, the first of two drugs in medication abortions, previously [...]
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was [...]
The F.D.A. Now Says It Plainly: Morning-After Pills Are Not Abortion Pills
Labels of Plan B One-Step had previously said, without scientific [...]
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 [...]
FDA Approves a Drug That Can Delay Type 1 Diabetes
The therapy will cost nearly $200,000. But it’s the first [...]
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
In use for 11 years, the drug Makena provided a [...]
What A.L.S. and Alzheimer’s Drug Approvals Have in Common
Regulators must balance patient’s needs with their safety.